Sensitivity and Specificity for 2,264,089 Screening Mammography Examinations from 2002 - 2006 --- based on BCSC data as of 2009

Notes

Numbers are frequencies unless otherwise indicated.

^* Sensitivity = the percentage of cancers that had an abnormal initial interpretation (BI-RADS category 4, 5, 0 -- category 3 with a recommendation for immediate follow-up was recoded as 0).

^† True Positive = the number of cancers that had an abnormal initial interpretation.

^‡ Cancers = the number of examinations with a tissue diagnosis of cancer within 1 year following the examination.

^§ Specificity = the percentage of non-cancers that had a negative initial interpretation (BI-RADS category 1, 2, or 3 with no recommendation for immediate follow-up).

^|| True Negative = the number of non-cancers that had a negative initial interpretation.

^# Non-cancers = the number of examinations without a tissue diagnosis of cancer within 1 year following the examination.

Table numbers last updated December 27, 2009. The following source must be cited when reproducing this table: NCI-funded Breast Cancer Surveillance Consortium co-operative agreement (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040). Downloaded xx/xx/xxxx from the Breast Cancer Surveillance Consortium Web site - http://breastscreening.cancer.gov/data/benchmarks/screening/2009/tableSensSpec.html .

[Return to Performance Benchmarks for Screening Mammography]